Axsome Therapeutics, Inc. AXSM 深 滬
已收盤 05-08 16:00:00 美东时间
217.38
-2.840
-1.29%
華盛通- 最 高223.43
- 今 開220.56
- 成交量 57.42万股
- 最 低 216.77
- 昨 收 220.22
- 總市值 111.86亿
- 52周最高 234.29
- 市盈率 靜 --
- 換手率 1.12%
- 52周最低 96.09
- 委 比 33.78%
- 總股本 5145.98万
- 歷史最高 234.29
- 量 比 0.43
- 振 幅 3.02%
- 歷史最低 1.94
- 每 手 1
- 風險率 31.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Health officials explored restricting specific antidepressants among SSRI drugs-sourcesKennedy announced other steps to reduce use of the medicines on MondayKennedy says SSRIs are overprescribed and, without evidence,
05-09 00:02
Axsome Therapeutics Recognizes Mental Health Month
Axsome Therapeutics supports Mental Health Month 2026, focusing on the theme "More Good Days Together." Nearly 1 in 4 U.S. adults lives with a mental illness, with major depressive disorder affecting over 21 million adults. Axsome highlights resources like Mental Health America's Action Guide, ADAA's therapist platform, and NAMI-NYC's events, emphasizing community support and accessible tools. The company also promotes the 988 Suicide & Crisis Li...
05-07 11:00
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Axsome COO Mark Jacobson disposes of common shares worth $1.08 million
Axsome COO Mark Jacobson disposes of common shares worth $1.08 million Axsome Therapeutics COO Mark L. Jacobson exercised stock options for 4,750 shares on May 4-5 at USD 12.95 per share. He sold 4,750 shares on May 4-5 at weighted average prices of USD 227.94 and USD 228.18, leaving 0 shares direct
05-06 08:35
U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi
U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi May 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Axsome Therapeutics and Onsemi on Tuesday. HIGHLIGHTS * Applied Materials AMAT
05-05 15:07
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
财报速睇 | Axsome Therapeutics, Inc. 2026财年Q1营收1.91亿美元，同比增长57.4%；归母净利润亏损0.65亿美元，同比亏损扩大8.6%
华盛资讯5月5日讯，Axsome Therapeutics, Inc.公布2026财年Q1业绩，公司Q1营收1.91亿美元，同比增长57.4%，归母净利润亏损0.65亿美元，同比亏损扩大8.6%。
05-05 05:47
Axsome一季度营收超预期 Auvelity峰值销售展望上调至80亿美元
Axsome Therapeutics于周一盘前公布了2026年第一季度财报，核心产品Auvelity持续强劲增长，公司同时宣布获FDA批准扩展至阿尔茨海默...
05-05 03:30
Axsome Therapeutics Q1 2026 Earnings Call: Complete Transcript
Axsome Therapeutics (NASDAQ:AXSM) held its first-quarter earnings conference ca...
05-04 21:24
Strong Drug Sales Lift Axsome Revenue, But Profit Miss Drags Stock
Axsome (AXSM) Q1: Revenue beats, but wider loss and rising expenses weigh on shares. Get the key data on Sunosi and Auvelity sales.
05-04 20:18
